review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Atul Purohit | |
Barry V L Potter | |||
Michael J Reed | |||
L W Lawrence Woo | |||
Christophe Thurieau | |||
Patrick Delavault | |||
Susannah J Stanway | |||
P433 | issue | 4 | |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 370-374 | |
P577 | publication date | 2007-04-01 | |
P1433 | published in | Oncologist | Q2122327 |
P1476 | title | Steroid sulfatase: a new target for the endocrine therapy of breast cancer | |
P478 | volume | 12 |
Q34561176 | Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: Structure–function studies and inhibitor development |
Q37145415 | Bacterial Lipopolysaccharides Induce Steroid Sulfatase Expression and Cell Migration through IL-6 Pathway in Human Prostate Cancer Cells |
Q57489669 | C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors |
Q36149395 | Current insights into the sulfatase pathway in human testis and cultured Sertoli cells |
Q37507823 | Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health |
Q37683048 | Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy |
Q58728345 | Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6) |
Q86296094 | Functional characterization of seven single-nucleotide polymorphisms of the steroid sulfatase gene found in a Japanese population |
Q33598615 | Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity |
Q64054345 | Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers |
Q36950482 | Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer |
Q34717459 | Membrane transporters for sulfated steroids in the human testis--cellular localization, expression pattern and functional analysis |
Q37774240 | Molecular therapy of breast cancer: progress and future directions |
Q101334765 | N-Phenyl-1,2,3,4-tetrahydroisoquinoline:an alternative scaffold for design of 17β-hydroxysteroid dehydrogenase 1 inhibitors |
Q38074097 | Oestrogen and colorectal cancer: mechanisms and controversies |
Q30841046 | Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps |
Q55353691 | Recent Advances in the Treatment of Breast Cancer. |
Q84977053 | Six Novel Single Nucleotide Polymorphisms of the Steroid Sulfatase Gene in a Japanese Population |
Q37681557 | Steroid hormone metabolizing enzymes in benign and malignant human bone tumors |
Q36775374 | Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma |
Q39459756 | Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495). |
Q34988257 | Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines. |
Q39288564 | Sulphamoylated estradiol analogue induces antiproliferative activity and apoptosis in breast cell lines. |
Q37094577 | Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate |
Q39935894 | Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities. |
Q64119664 | Targeting stem cells in the realm of drug-resistant breast cancer |
Q38953235 | Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015). |
Q33809605 | The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers |
Q39669160 | The in vitro effects of 2-methoxyestradiol-bis-sulphamate on cell numbers, membrane integrity and cell morphology, and the possible induction of apoptosis and autophagy in a non-tumorigenic breast epithelial cell line. |
Q36651350 | The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors |
Q36796680 | The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer |
Search more.